David Mehalick - Net Worth and Insider Trading
David Mehalick Net Worth
The estimated net worth of David Mehalick is at least $1 Million dollars as of 2024-05-12. David Mehalick is the CEO and President, 10% Owner of Coeptis Therapeutics Holdings Inc and owns about 2,782,615 shares of Coeptis Therapeutics Holdings Inc (COEP) stock worth over $1 Million. Details can be seen in David Mehalick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Mehalick has not made any transactions after 2024-01-08 and currently still holds the listed stock(s).
Transaction Summary of David Mehalick
David Mehalick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Mehalick owns 1 companies in total, including Coeptis Therapeutics Holdings Inc (COEP) .
Click here to see the complete history of David Mehalick’s form 4 insider trades.
Insider Ownership Summary of David Mehalick
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings Inc | 2024-01-08 | director & 10 percent owner & CEO and President |
David Mehalick Latest Holdings Summary
David Mehalick currently owns a total of 1 stock. David Mehalick owns 2,782,615 shares of Coeptis Therapeutics Holdings Inc (COEP) as of January 8, 2024, with a value of $1 Million.
Latest Holdings of David Mehalick
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings Inc | 2024-01-08 | 2,782,615 | 0.38 | 1,066,298 |
Holding Weightings of David Mehalick
David Mehalick Form 4 Trading Tracker
According to the SEC Form 4 filings, David Mehalick has made a total of 1 transactions in Coeptis Therapeutics Holdings Inc (COEP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coeptis Therapeutics Holdings Inc is the acquisition of 25,054 shares on January 8, 2024, which cost David Mehalick around $16,786.
Insider Trading History of David Mehalick
- 1
David Mehalick Trading Performance
GuruFocus tracks the stock performance after each of David Mehalick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Mehalick is -47.75%. GuruFocus also compares David Mehalick's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Mehalick within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Mehalick's insider trading performs compared to the benchmark.
Performance of David Mehalick
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -28.33 |  | | | | |
| Relative Return to S&P 500(%) | -33.25 | | | | | |
David Mehalick Ownership Network
David Mehalick Owned Company Details
What does Coeptis Therapeutics Holdings Inc do?
Who are the key executives at Coeptis Therapeutics Holdings Inc?
David Mehalick is the director & 10 percent owner & CEO and President of Coeptis Therapeutics Holdings Inc. Other key executives at Coeptis Therapeutics Holdings Inc include director & VP of Operations Daniel Alexander Yerace , director & 10 percent owner & Chief Financial Officer Chris Calise , and CFO and Secretary Christine Elise Sheehy .
Coeptis Therapeutics Holdings Inc (COEP) Insider Trades Summary
Over the past 18 months, David Mehalick made 1 insider transaction in Coeptis Therapeutics Holdings Inc (COEP) with a net purchase of 25,054. Other recent insider transactions involving Coeptis Therapeutics Holdings Inc (COEP) include a net purchase of 44,244 shares made by Gene Salkind , a net purchase of 11,582 shares made by Chris Calise , and a net purchase of 10,850 shares made by Daniel Alexander Yerace .
In summary, during the past 3 months, insiders sold 0 shares of Coeptis Therapeutics Holdings Inc (COEP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Coeptis Therapeutics Holdings Inc (COEP) were sold and 105,996 shares were bought by its insiders, resulting in a net purchase of 105,996 shares.
Coeptis Therapeutics Holdings Inc (COEP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Coeptis Therapeutics Holdings Inc Insider Transactions
David Mehalick Mailing Address
Above is the net worth, insider trading, and ownership report for David Mehalick. You might contact David Mehalick via mailing address: 5000 Tressdale Drive, Gibsonia Pa 15044.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
